Selective inhibitors of zinc-dependent histone deacetylases. Therapeutic targets relevant to cancer.

Abstract:

:Histone deacetylases (HDACs), which act on acetylated histones and/or other non-histone protein substrates, represent validated epigenetic targets for the treatment of cancer and other human diseases. The inhibition of HDAC activity was shown to induce cell cycle arrest, differentiation, apoptosis as well as a decrease in proliferation, angiogenesis, migration, and cell resistance to chemotherapy. Targeting single HDAC isoforms with selective inhibitors will help to reveal the role of individual HDACs in cancer development or uncover further biological consequences of protein acetylation. This review focuses on conventional zinc-containing HDACs. In its first part, the biological role of individual HDACs in various types of cancer is summarized. In the second part, promising HDAC inhibitors showing activity both in enzymatic and cell-based assays are surveyed with an emphasis on the inhibitors selective to the individual HDACs.

journal_name

Curr Pharm Des

authors

Kollar J,Frecer V

doi

10.2174/1381612820666141110164604

subject

Has Abstract

pub_date

2015-01-01 00:00:00

pages

1472-502

issue

11

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-63303

journal_volume

21

pub_type

杂志文章,评审
  • The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders.

    abstract::Multiple molecular, cellular, structural and functional changes occur in the brain during aging. Neural cells may respond to these changes adaptively by employing multiple mechanisms in order to maintain the integrity of nerve cell circuits and to facilitate responses to environmental demands. Otherwise, they may succ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210790883741

    authors: Lanni C,Stanga S,Racchi M,Govoni S

    更新日期:2010-01-01 00:00:00

  • Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update.

    abstract::The incidence of diabetes has increased globally in recent years and figures of diabetic patients were estimated to rise up to 642 million by 2040. The disorder is accompanied with various complications if not managed at the early stages, and interlinked high mortality rate and morbidity with time. Different classes o...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190717104547

    authors: Usman B,Sharma N,Satija S,Mehta M,Vyas M,Khatik GL,Khurana N,Hansbro PM,Williams K,Dua K

    更新日期:2019-01-01 00:00:00

  • Peptide activators of the p53 tumor suppressor.

    abstract::The oncoproteins MDM2 and MDMX negatively regulate the activity and stability of the p53 tumor suppressor, directly contributing to the development and progression of many tumors harboring wild type p53. Antagonizing MDM2 and MDMX to activate the p53 pathway has thus become an attractive new strategy for anticancer dr...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211795222577

    authors: Zhan C,Lu W

    更新日期:2011-01-01 00:00:00

  • Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease.

    abstract:BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) is a global epidemic involving 20-40% of the general population. NAFLD is rapidly becoming the leading cause of hepatocellular carcinoma (HCC) worldwide. Knowledge about NAFLD-HCC peculiar features is needed to understand this emerging disease better. OBJECTIVE:To r...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200429093648

    authors: Tovoli F,Ferri S,Piscaglia F

    更新日期:2020-01-01 00:00:00

  • Synthetic lethality and PARP-inhibitors in oral and head & neck cancer.

    abstract::Head and neck cancer refers to a group of malignancies that affects the epithelium of the upper aereodigestive tract, primarily the lip and mouth, pharynx and larynx. Head and neck cancer is strongly associated with tobacco smoking, alcohol consumption and betel nut chewing, and indeed a reduction in the exposure to t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212803307608

    authors: Forster M,Mendes R,Fedele S

    更新日期:2012-01-01 00:00:00

  • Proteomic-based analysis for identification of proteins involved in 5-fluorouracil resistance in hepatocellular carcinoma.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) has high mortality partly due to acquiring drug resistance during chemotherapy treatment. Therefore, it is necessary to explore the underlying mechanism of drug resistance. METHODS:We used 2-DE and MALDI-TOF-MS analysis to explore the possible molecular insight into 5-FU resis...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161282001140113125143

    authors: Tan Y,Qin S,Hou X,Qian X,Xia J,Li Y,Wang R,Chen C,Yang Q,Miele L,Wu Q,Wang Z

    更新日期:2014-01-01 00:00:00

  • Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.

    abstract::The majority of pharmaceutical formulations for the treatment of ocular pathologies are for topical administration. However, this kind of ophthalmic formulations has disadvantages such as low bioavailability and, consequently, a reduced therapeutic effect. This happens due to the anatomical and physiological specifici...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150923095155

    authors: Almeida H,Amaral MH,Lobao P,Frigerio C,Sousa Lobo JM

    更新日期:2015-01-01 00:00:00

  • Metal/Metal Oxide Nanoparticles: Toxicity, Applications, and Future Prospects.

    abstract::The ever-growing resistance of pathogens to antibiotics and crop disease due to pest has triggered severe health concerns in recent years. Consequently, there is a need of powerful and protective materials for the eradication of diseases. Metal/metal oxide nanoparticles (M/MO NPs) are powerful agents due to their ther...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666191111091326

    authors: Chaudhary RG,Bhusari GS,Tiple AD,Rai AR,Somkuvar SR,Potbhare AK,Lambat TL,Ingle PP,Abdala AA

    更新日期:2019-01-01 00:00:00

  • Ras signaling pathway proteins as therapeutic targets.

    abstract::Ras is a 21 kDa membrane-localized G protein that is coupled to receptor and non-receptor tyrosine kinase activation of downstream cytoplasmic and nuclear events. Mutated ras genes are common, and occur in a wide variety of human malignancies. These activating mutations result in constitutive signaling, thereby stimul...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612013397258

    authors: Adjei AA

    更新日期:2001-11-01 00:00:00

  • An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment.

    abstract::Repurposing already approved drugs as new anticancer agents is a promising strategy considering the advantages such as low costs, low risks and less time-consumption. Disulfiram (DSF), as the first drug for antialcoholism, was approved by the U.S. Food and Drug Administration (FDA) over 60 years ago. Increasing eviden...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190816233755

    authors: Yang Q,Yao Y,Li K,Jiao L,Zhu J,Ni C,Li M,Dou QP,Yang H

    更新日期:2019-01-01 00:00:00

  • Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?

    abstract::While pharmacological blockade of dopamine D2 receptor can effectively suppress the psychotic or positive symptoms of schizophrenia, there is no satisfactory medication for the negative and cognitive symptoms of schizophrenia in spite of the proliferation of second generation antipsychotic drugs. Excitements over a ne...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150724100952

    authors: Singer P,Dubroqua S,Yee BK

    更新日期:2015-01-01 00:00:00

  • Apoptosis pathways and neuroblastoma therapy.

    abstract::Evasion of apoptosis, the cell's intrinsic death program, is a hallmark of human cancers including neuroblastoma. Also, failure to undergo apoptosis may cause treatment resistance, since the cytotoxic activity of anticancer therapies commonly used in the clinic, e.g. chemotherapy, gamma-irradiation or immunotherapy, i...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209787315846

    authors: Fulda S

    更新日期:2009-01-01 00:00:00

  • Pharmacogenetics of phase I and phase II drug metabolism.

    abstract::Genetic variation in the receptors and other intracellular targets that mediate the pharmacodynamic effects of drugs can affect therapeutic outcomes. However, at present greater knowledge is available concerning the extent of gene variation in drug metabolizing enzymes that determine drug pharmacokinetics and, in turn...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210790112674

    authors: Crettol S,Petrovic N,Murray M

    更新日期:2010-01-01 00:00:00

  • Cell elimination as a strategy for repair in acute spinal cord injury.

    abstract::Following injury, as part of the wound-healing process, cell proliferation occurs mostly to replace damaged cells and to reconstitute the tissue back to normal condition/function. In the spinal cord some of the dividing cells following injury interfere with the repair processes. This interference occurs at the later s...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612053507477

    authors: Kalderon N

    更新日期:2005-01-01 00:00:00

  • Natural Cytotoxic Diterpenoids, a Potential Source of Drug Leads for Melanoma Therapy.

    abstract::Diterpenes present complex structure and due to their unique carbon skeleton and interesting biological activities, have been the focus of continuous studies for the development of new anticancer agents. Phorbol esters have been known for their activity against skin malignancies since ancient times. Taxol was first st...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190111143648

    authors: Prieto JM,Silveira D

    更新日期:2018-01-01 00:00:00

  • Frontal lobe synaptic plasticity in development and disease: modulation by the dopamine D1 receptor.

    abstract::Synaptic plasticity is now known to occur at glutamate synapses throughout the brain, including the neocortex, and to play a role in neurodevelopment as well as in a broad spectrum of adult neural functions. Here the hypothesis that synaptic plasticity, specifically long term depression, is the neural substrate that m...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612819666140110122307

    authors: Selemon LD

    更新日期:2014-01-01 00:00:00

  • Clinical applications and biosafety of human adult mesenchymal stem cells.

    abstract::Mesenchymal Stem Cells (MSCs) are a population of adherent cells that can differentiate into mesenchymal lineage populations (cartilage, bone and fat tissue). In addition, they seem to be able to differentiate also into a broader type of lineages other than the original mesodermal germ layer. Bone marrow MSCs are a st...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799859666

    authors: Mariani E,Facchini A

    更新日期:2012-01-01 00:00:00

  • Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer's Disease.

    abstract::Age-associated cognitive decline and dementia are conditions in which there is deterioration in memory, thinking, and behavior, with profound effects on the ability to perform everyday activities and well-being. Even if dementia mainly affects older persons, it is not a normal part of aging. Alzheimer's disease accoun...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612822666151204000733

    authors: Dominguez LJ,Barbagallo M

    更新日期:2016-01-01 00:00:00

  • RNAi in Plasmodium.

    abstract::RNA interference (RNAi) has quickly proven to be an immensely useful tool for studying gene function and validation of potential drug targets in almost all organisms that possess the required set of proteins of the interference pathway. In protozoan parasites like Plasmodium, Toxoplasma, Entamoeba, Giardia, Trypanosom...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990027

    authors: Mueller AK,Hammerschmidt-Kamper C,Kaiser A

    更新日期:2014-01-01 00:00:00

  • Advanced glycation end products and insulin resistance.

    abstract::Non-enzymatic modification of proteins by reducing sugars, a process that is also known as Maillard reaction, leads to the formation of advanced glycation end products (AGEs) in vivo. There is a growing body of evidence that formation and accumulation of AGEs progress during normal aging, and at an extremely accelerat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208784139747

    authors: Unoki H,Yamagishi S

    更新日期:2008-01-01 00:00:00

  • Pituitary Adenylyl Cyclase Activating Polypeptide (PACAP) Signaling and the Cell Cycle Machinery in Neurodegenerative Diseases.

    abstract::Pituitary adenylyl cyclase activating polypeptide (PACAP) is a neuropeptide with great neuroprotective effects and remarkable therapeutic potential. PACAP activates several cellular pathways to exert its protective effects. Emerging evidence shows that PACAP can modify the levels and activity of cell cycle components ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666181127102311

    authors: Polanco MJ,Pennuto M

    更新日期:2018-01-01 00:00:00

  • Removal and Extraction of Carboxylic Acids and Non-ionic Compounds with Simple Hydroxides and Layered Double Hydroxides.

    abstract::Carboxylic acids are an important natural component as a final product or intermediates for syntheses. They are produced in plants, animals and also as products from biotechnological processes. This review presents the use of single hydroxide particles and layered double hydroxides as alternative adsorbents to remove ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666191226103623

    authors: Rodriguez LEG,Bail A,Castillo RO,Arízaga GGC

    更新日期:2020-01-01 00:00:00

  • Intervention guidelines for neonatal hyperbilirubinemia: an evidence based quagmire.

    abstract::The American Academy of Pediatrics has proposed guidelines for treating term/near term infants with hyperbilirubinemia based primarily on maintaining the total serum bilirubin concentration (TSB) below a "critical" level of 25 mg/dL (426 micromol/L). We estimated the sensitivity and specificity of this critical TSB us...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209789058228

    authors: Wennberg RP,Ahlfors CE,Aravkin AY

    更新日期:2009-01-01 00:00:00

  • Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms.

    abstract::The last quarter of a century has witnessed remarkable progress in the understanding of phosphoinositide 3-kinases (PI3K) signalling and their involvement in different diseases such as cancer, diabetes and inflammation. Nevertheless, many questions remain open and among these the role of genetic and epigenetic regulat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Fyffe C,Buus R,Falasca M

    更新日期:2013-01-01 00:00:00

  • Leptin and the OB-receptor as anti-obesity target: recent in silico advances in the comprehension of the protein-protein interaction and rational drug design of anti- obesity lead compounds.

    abstract::The OB-receptor or leptin receptor (LR) is crucial for energy homeostasis and regulation of food uptake. Leptin is a 16 kDa hormone that is mainly secreted by fat cells into the bloodstream. Under normal circumstances, circulating leptin levels are proportionate to the fat body mass. Sensing of elevated leptin levels ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113196660743

    authors: Tutone M,Lauria A,Almerico AM

    更新日期:2014-01-01 00:00:00

  • MALT Lymphoma, Stress Ulcer and Cholinergic Nerves from the Viewpoint of Bilateral and Unilateral Truncal Vagotomy and Substance P.

    abstract:BACKGROUND:Vagal nerve plays an important role in the stomach function. The cholinergic nerves are the most abundantly distributed nerves in the gastric tissue. It has recently been reported that the vagal nerve is significantly related to both gastric cancer development and progression. However, its relation to the me...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180516103027

    authors: Kodama Y,Sasaki K,Murasato F,Overby A,Takahashi S,Murayama SY,Matsui H,Nakamura M

    更新日期:2018-01-01 00:00:00

  • Identification of molecular targets associated with ethanol toxicity and implications in drug development.

    abstract::Alcohol dependence is a major disease burden of adults in modern society worldwide. There is no cure for alcohol dependence. In this study, we have examined the molecular targets of ethanol-induced toxicity in humans based on a systematic review of literature data and then discussed current and potential therapeutic t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210791034030

    authors: Wang LL,Yang AK,He SM,Liang J,Zhou ZW,Li Y,Zhou SF

    更新日期:2010-01-01 00:00:00

  • Perioperative Management of Patients Receiving New Anticoagulants.

    abstract::There is an increased use of oral anticoagulants for the prevention of venous and arterial thrombosis. Vitamin-K antagonists have been used for decades as the main oral anticoagulants but they have the draback a complex therapeutic management, slow onset of action and by a different oral intake caused by dietary vitam...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190709220449

    authors: Lamperti M,Khozenko A,Kumar A

    更新日期:2019-01-01 00:00:00

  • Deubiquitinating enzymes as promising drug targets for infectious diseases.

    abstract::Deubiquitinating enzymes (DUBs) remove ubiquitin and ubiquitin-like modifications from proteins and they have been known to contribute to processes relevant in microbial infection, such as immune responses pathways. Numerous viral and bacterial DUBs have been identified, and activities of several host DUBs are known t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319180008

    authors: Nanduri B,Suvarnapunya AE,Venkatesan M,Edelmann MJ

    更新日期:2013-01-01 00:00:00

  • Subcutaneous Immunoglobulins: A Promising Alternative for Immunomodulation?

    abstract::Cumulative recent evidence from clinical trials, observational studies and case reports has shown that subcutaneous administration of immunoglobulin (SCIg) exerts similar immunomodulatory capacity than intravenous immunoglobulin (IVIg) in autoimmune neurological diseases. Besides the beneficial clinical effects, the p...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160831103806

    authors: Sanchez-Ramon S,Corbi AL,Fidalgo AG,Dominguez-Soto A

    更新日期:2016-01-01 00:00:00